We describe a method based on a single stable reagent for the determination of calcium in serum and plasma with use of Arsenazo III, 200 imoI/L in 50 mmol/L 1,4-piperazinediethanesulfonic acid (PIPES) buffer. The method showed significantpositive interference in plasma at pH <6.6 because of the precipitation of fibrinogen, which was eliminated by increasing the pH to 6.8. The assay showed no interference from as much as 600 /.Lrnol of bilirubin and 12 g of hemoglobin per liter when applied The OCPC procedure for serum and plasma calcium has been extensively investigated, but there is a paucity of such information for Arsenazo Ill. We sought to establish a procedure based on the use of Arsenazo III that would yield accurate results in normal, icteric, hemolyzed, and lipemic samples. The reagent would then be readily adaptable to most instrumentation. 
the reaction proceeds under slightly acidic conditions, bicarbonate absorption is greatly decreased and so calibration stability is enhanced. At least three commercial instrument companies (8) (9) (10) have produced Arsenazo Ill formulations for calcium measurement on their instruments.
Although other instrument applications are produced for these formulations, little information accompanies such applications with regard to chromophoric interference, laboratory utility, and comparability with values from external quality-assurance schemes. A recent evaluation (11) of serum calcium measurement with The OCPC procedure for serum and plasma calcium has been extensively investigated, but there is a paucity of such information for Arsenazo Ill. We sought to establish a procedure based on the use of Arsenazo III that would yield accurate results in normal, icteric, hemolyzed, and lipemic samples. The reagent would then be readily adaptable to most instrumentation.
MaterIals and Methods

1,4-Piperazinediethanesulfonic
acid (PIPES) sodium salt, 4-morpholinoethanesulfonic acid (MES), Arsenazo ifi, and bilirubin (from gall stones) were obtained from Sigma Chemical Co. Ltd., London, U.K. Intralipid was obtained from Kabivitrium (Cahill May Roberts, Dublin, Ireland). All other chemicals were purchased from BDH (Poole, U.K.) and were Analar grade.
ChromophoresEvaluated
Aliquots of whole blood from 50 patients were pooled and the plasma was separated.
Increasing
hemolysis.
An aliquot of the packed cells was placed in an ultrasonic bath for 5 mm to lyse the erythrocytes. The hemolysate was added to the plasma pool to give various amounts of hemoglobin. The hemoglobin was quantified as the cyanmethemoglobin derivative with the Technicon Hi analyzer (Technicon Instruments, Tarrytown, NY). 
Increasing icterus.
Various volumes of bilirubin solution, 100 mmol/L dissolved in 100 mmol/L NaOH, were added to a plasma pool. The pH of the sample did not change by more than 0.1 units and the addition of the NaOH did not affect the assay. We compensated for the 
PIPES mmol/L
Analytical Variables
Imprecision. Three quality-control materials were assayed 20 times consecutively to determine the withinrun variation. The samples were again run randomly four times each day for five days to determine the between-run variation.
Linearity.
Linearity was assessed with aqueous calcium carbonate dissolved in dilute hydrochloric acid and made up to volume in physiological saline. All patients' samples were collected in Greiner (C. A. Greiner GmbH, Greinerstrasse, Austria) evacuated primary sample tubes.
Calibration.
Decision III (Beckman Instruments, Brea, CA) was used throughout for calibration. Reagent concentrations are discussed in Results.
Results
Assay Optimization
Because some of the commercial formulations of Arsenazo Ill have pH values close to 6.0 (8,9), we initially Table 1 ]. Therefore, we chose pH 6.8 for subsequent work, because the linearity achievable at this pH was acceptable. Under these conditions the absorbance of the blank reagent at 660 nm was 0.35 and that of the 3.18 mmol/L calibrator was 1.00, so that the absorbance change was 0.2 A per mmolJL of calcium.
Analytical Variables
Correlation.
Results for 100 patients' samples, calcium range 1.07-3.71 mmol/L, showed good agreement with results by the AAS procedure (Figure 3) . The Bilirubin pmol/L The 660/546 and 600/546 nm assays predictably showed negative interference because of the greater absorbance contributed by lipemia at 546 ma than at 660 ma.
Effects of hemolysis.
Increasing concentrations of hemoglobin were added to the plasma pool and the assay was performed under the four protocols. 
Atomic Absorption Calcium (mmol!L)
Fig. 3. Correlationof resultsby the PIPES/Arsenazo Ill methodwith those by atomicabsorptionspectrophotometry
Because many wet-chemistry discrete analyzers use bichromatic subtraction for single-reagent methods, we investigated the effect of chromophoric interference in one monochromatic and three bichromatic procedures. Figure   4a shows that bilirubin at 600 tmol/L slightly interferes with the 660/546 nm and the 600/546 nm bichromatic calcium procedures. The monochromatic procedure at 600 and the 660/700 nm bichromatic procedure were completely free from the interference.
Effect of bilirubin.
Effect of In.tralipid.
Increasing concentrations
of Intralipid were added to the plasma pool and the assay was performed under the four protocols. Figure 4b showsthat the 660/700 nm method was little affected by The procedure described here demonstrates twice the sensitivity (for a similar sample volume fraction) and little effect from hemolysis with the 660-ma protocol open-vial calibration stability is enhanced; the assay is essentially free from interference from hemolysis, lipemia, and icterus; and assay linearity is acceptable at all pathophysiological concentrations.
In summary, the procedure we describe is readily adaptable to a manual procedure or to any discrete or continuous-flow type of analyzer. We describe a study made at two pediatric centers to test experimental lancets for blood collection by skin puncture of infants' heels or fingers. Our primary goal is to decrease the hazard of osseous injury while collecting adequate blood, by using three lancet widths at a constant length of 1.0 mm. The three widths used were 1.0, 1.25, and 1.5 mm. When success at skinpuncture was defined rigidly on the basis of the blood volume obtained, the data show that success was related neither to the lancets' dimensions as tested nor to the age of the child, but rather to the phlebotomist's skill and experience, which improved with time.
AddItionalKeyphrasee:pediatric chemistry vanation, source Of Past reports on the skin puncture of infants' heels revealed that the distance from skin surface to bone (calcaneus) increases with weight and age during the first 6 months of life (1) (2) (3) . For this age interval, we recommended the use of 1.8-mm-long lancets for heel puncture (2, 3). Such lancets, however, are hazardous for the finger puncture of infants older than about 6 months because the distal phalanx may have a skinsurface-to-bone depth of 1.5 mm or less. When the hitherto unmeasured effect of compressionduring finger puncture is also considered, 1.5 mm seems indisputably excessive for the length of such a lancet.
A proposal was made4 to minimize the risk of bone 
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